tiprankstipranks
Trending News
More News >
Good Fellow Healthcare Holdings Limited (HK:8143)
:8143
Hong Kong Market

Good Fellow Healthcare Holdings Limited (8143) AI Stock Analysis

Compare
0 Followers

Top Page

HK:8143

Good Fellow Healthcare Holdings Limited

(8143)

Select Model
Select Model
Select Model
Underperform 39 (OpenAI - 5.2)
Rating:39Underperform
Price Target:
HK$0.09
▼(-50.53% Downside)
Action:DowngradedDate:03/04/26
The score is weighed down primarily by weak financial performance (sharp revenue decline, large losses, and negative equity), with technical indicators also indicating a sustained downtrend. Valuation provides little support given negative earnings and no dividend data.
Positive Factors
Gross margin resilience
A sustained gross margin near 52% indicates the company retains pricing power or efficient direct-cost control for its care services. This margin buffer can support recovery efforts by absorbing fixed costs and gives management room to restore profitability as revenue stabilizes.
Positive operating cash flow
Generating positive operating cash flow despite accounting losses shows the core business can convert service delivery into cash. That operational cash generation provides liquidity runway and supports working-capital needs while management executes restructuring or growth strategies.
Free cash flow conversion close to net loss
Free cash flow nearly matches net losses, implying much of the reported loss is non-cash or offset by cash-driven operations. This structural trait suggests the business can sustain operations and finance near-term obligations without immediate equity dilution if cash conversion remains consistent.
Negative Factors
Sharp revenue decline
A ~31% drop in revenue materially reduces scale and undermines fixed-cost absorption in care facilities, lengthening recovery timelines. Persistently lower volumes weaken bargaining power, reduce margin leverage, and increase the risk that cost cuts will be insufficient to restore sustainable profitability.
Deep net losses
Severe negative margins indicate current operations destroy shareholder value and limit internal funding for reinvestment. Sustained large losses erode capital buffers, constrain strategic options, and make it harder to invest in service quality or capacity needed to regain market position.
Negative shareholders' equity and leverage risk
Negative equity and a negative debt-to-equity ratio signal capital inadequacy and heightened solvency risk. This structural weakness restricts access to conventional financing, increases refinancing and covenant risk, and may force dilutive recapitalization or asset sales to restore balance-sheet health.

Good Fellow Healthcare Holdings Limited (8143) vs. iShares MSCI Hong Kong ETF (EWH)

Good Fellow Healthcare Holdings Limited Business Overview & Revenue Model

Company DescriptionGood Fellow Healthcare Holdings Limited, an investment holding company, provides general hospital services in the People's Republic of China and internationally. Its general hospital services include medical and surgical wards, and medical checkup and examination. As of March 31, 2022, the company operated two general hospitals in Putain and Beijing. It also provides medical investment and hospital management services; and hospital consulting management. The company was formerly known as Hua Xia Healthcare Holdings Limited and changed its name to Good Fellow Healthcare Holdings Limited in February 2019. The company was incorporated in 2001 and is headquartered in Central, Hong Kong. Good Fellow Healthcare Holdings Limited is a subsidiary of Solar Star Global Limited.
How the Company Makes MoneyGood Fellow Healthcare Holdings Limited generates revenue through multiple streams, including the sale of medical equipment and supplies to healthcare institutions and professionals. The company also earns income from healthcare management services, which involve consulting and operational support for healthcare facilities. Additionally, revenue is derived from wellness programs designed to promote health and prevent illness among consumers. Strategic partnerships with healthcare providers and suppliers further enhance the company's market reach and contribute to its earnings, allowing it to leverage synergies and expand its service offerings.

Good Fellow Healthcare Holdings Limited Financial Statement Overview

Summary
Financial statements indicate severe weakness: revenue fell sharply (-30.73%), profitability is deeply negative (net margin -62.82% with negative EBIT/EBITDA), and the balance sheet shows negative shareholders’ equity and high leverage risk. Operating cash flow is positive but overall cash generation quality is weak with sharply negative free cash flow growth (-116.36%).
Income Statement
30
Negative
The company has experienced a significant decline in revenue, with a revenue growth rate of -30.73% in the most recent year. Gross profit margin is relatively stable at 51.92%, but the net profit margin is deeply negative at -62.82%, indicating substantial losses. EBIT and EBITDA margins are also negative, reflecting operational challenges.
Balance Sheet
20
Very Negative
The balance sheet shows a concerning negative stockholders' equity, leading to a negative debt-to-equity ratio of -1.62. Return on equity is alarmingly high at 155.58%, driven by negative equity, indicating financial instability. The equity ratio is negative, suggesting the company is heavily reliant on debt financing.
Cash Flow
40
Negative
The company has managed to generate positive operating cash flow, but free cash flow growth is negative at -116.36%. The operating cash flow to net income ratio is low at 0.16, and free cash flow to net income ratio is close to 1, indicating limited cash flow generation relative to net losses.
BreakdownMar 2024Mar 2023Mar 2022Mar 2021Mar 2021
Income Statement
Total Revenue16.12M38.96M55.35M54.24M53.89M
Gross Profit8.37M18.67M27.01M26.66M26.45M
EBITDA1.86M-10.12M1.83M4.38M-23.55M
Net Income-10.13M-17.11M-5.88M-12.69M-30.18M
Balance Sheet
Total Assets9.83M29.15M41.70M60.45M191.38M
Cash, Cash Equivalents and Short-Term Investments4.14M3.88M18.36M25.15M44.89M
Total Debt10.53M12.23M4.49M7.36M29.73M
Total Liabilities16.59M27.74M22.32M34.08M158.48M
Stockholders Equity-6.51M4.36M22.19M29.59M40.23M
Cash Flow
Free Cash Flow2.58M-15.35M-3.84M-24.51M-21.21M
Operating Cash Flow2.62M-854.00K-1.32M-22.93M1.25M
Investing Cash Flow-1.57M-14.46M5.74M2.19M-24.28M
Financing Cash Flow1.06M4.36M-2.75M-5.61M4.83M

Good Fellow Healthcare Holdings Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.19
Price Trends
50DMA
0.16
Negative
100DMA
0.17
Negative
200DMA
0.15
Negative
Market Momentum
MACD
-0.01
Negative
RSI
34.68
Neutral
STOCH
17.16
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8143, the sentiment is Negative. The current price of 0.19 is above the 20-day moving average (MA) of 0.13, above the 50-day MA of 0.16, and above the 200-day MA of 0.15, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 34.68 is Neutral, neither overbought nor oversold. The STOCH value of 17.16 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8143.

Good Fellow Healthcare Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
HK$193.18M5.317.84%8.00%-21.50%-43.25%
61
Neutral
HK$112.94M-6.98-10.31%-11.68%-71.01%
58
Neutral
HK$63.87M362.73-19.93%-2.91%55.41%
53
Neutral
HK$22.88M-197.60125.77%-20.81%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
41
Neutral
HK$19.31M-2.2914.64%-81.95%
39
Underperform
HK$112.73M-20.58-132.60%-30.45%-734.38%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8143
Good Fellow Healthcare Holdings Limited
0.11
0.06
127.66%
HK:2293
Bamboos Health Care Holdings Ltd
0.48
-0.15
-23.81%
HK:8161
MediNet Group Ltd.
0.55
0.17
44.74%
HK:8307
Medicskin Holdings Ltd.
0.16
-0.03
-14.36%
HK:8357
Republic Healthcare Limited
0.19
0.12
189.23%
HK:8437
RMH Holdings Limited
0.28
0.16
133.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 04, 2026